Data Interpretation

Innovations Designed to Empower Clinicians, Educators and Caregivers

Related Resources

Podcast Episode 16: CGM Insights - Unveiling Cutting-Edge Clinical Evidence for Type 2 Diabetes Management

Premium Content

Off

Podcast Episode 21: Clinical Accuracy in CGM and Why It Matters

alexa.stelzer — Mon, 03 Jun 2024 16:25:53 +0000

Podcast Episode 21: Clinical Accuracy in CGM and Why It Matters

06/04/2024

alexa.stelzer Mon, 06/03/2024 - 16:25

Guest Speakers: Dr. Jessica Castle and Dr. Stayce Beck

Real-time real talk is intended for healthcare professionals in the US.

In this episode of Real Time Real-Talk, host Cher Pastore is joined by Dr. Jessica Castle and Dr. Stayce Beck to discuss the process behind the formulation and execution of continuous glucose monitoring (CGM) accuracy trials.

The trio discuss the influence of rigorous trial design and transparency on the accuracy and reliability of CGM devices, particularly those developed by Dexcom. They highlight the importance of CGM research's credibility, strategies to minimize bias, and the essential role that regulatory bodies play in ensuring quality health research. The discussion also covers the dynamics of conflicts of interest, patient and healthcare provider education, and the significance of detailed metrics for evaluating CGM performance.

Our expert panel also take us behind the scenes to reveal the meticulous work involved in creating and executing CGM studies that encompass different populations and conditions. The episode includes discussions around key performance metrics in a CGM accuracy study, understanding why blood glucose monitor and CGM readings might not match and the explanation of relative difference and CGM accuracy.

Finally, listen as they walk through the process of bringing transparency to CGM data analysis, alongside discussing the potential challenges and future of CGM device application in pediatric hospital discharge programs, probing into the potential barriers and challenges faced by healthcare providers and patients.

The conversation highlights the comprehensive journey towards ensuring users can trust their CGM readings, right from day one to real-world applications.

Accuracy of the Seventh Generation of Dexcom CGM

Podcasts

Yes

Jessica Castle, MD

Dr Castle is board-certified adult endocrinologist with 15 years of experience in clinical trials in the field of diabetes. She served as the Associate Director of the Harold Schnitzer Diabetes Health Center, where they provided care to 5,900 patients living with diabetes. She is also board-certified in internal medicine. Her clinical trial experience includes obtaining 11 investigational device exemptions from the FDA for automated insulin delivery and decision support studies. She has been on numerous data safety monitoring boards, including boards overseeing multiple large multi-center automated insulin delivery trials and for trials based both in the US and in Europe.

Related Resources

Podcast Episode 22: Revolutionizing Hospital Discharge Planning with CGM Technology

Premium Content

Off

Case Study: Real-Life Application of CGM Data Interpretation

OlgaDalisay — Mon, 18 Mar 2024 23:17:55 +0000

Case Study: Real-Life Application of CGM Data Interpretation

03/18/2024

OlgaDalisay Mon, 03/18/2024 - 23:17

Learn how an AGP report can provide more informed decision-making, insights into therapy adjustments, and transform patients' overall well-being.

In this short ~6 min video, David Doriguzzi, PA-C, goes over a recent case study in his practice showcasing the journey of a patient with T2D who achieved significant improvements in their glycemic metrics by adding real-time CGM to the treatment plan. With addition of CGM to the picture, this patient had increased their time in target glucose range by almost 50% in just 1 month.

"...we are really only able to dial in [medication] by having an understanding of where the patient started, what her needs were, and how her glucose responded at different times of the day based on that CGM data ..."

Finally, Dr Doriguzzi goes over the specifics of CGM interpretation reimbursement criteria.

More about AGP report and Data Interpretation.

Expert Presentations

Expert Presentations - Type 2 Diabetes

Expert Presentations - Data Interpretation

Expert Presentations - Reimbursement

Country

United States

David Doriguzzi, PA-C

David Doriguzzi, PA-C has been practicing since 2002 in internal medicine and endocrinology. He graduated from Loma Linda University PA program in 2002 and specializes primarily in diabetes and thyroid management. He works in Lancaster, CA as a physician assistant and is actively involved in educating other healthcare providers in the area of diabetes management.

Premium Content

CGM 101: Resources for Patients

OlgaDalisay — Thu, 07 Mar 2024 20:57:19 +0000

CGM 101: Resources for Patients

03/07/2024

OlgaDalisay Thu, 03/07/2024 - 20:57

At SIGMA we value your time and strive to help you deliver high-quality care, optimize practice workflows, and achieve better outcomes for both you and your patients.

Your meter measures glucose levels at a single moment in time, while CGM continually check glucose levels throughout the day and night and can alert you if your glucose levels go too high or too low.

This new resource provides an overview of Continuous Glucose Monitoring: what it is, how it works as well as useful tips on utilizing the features of a CGM system.

You can download this brochure and use it in:

Conversations with new patients on CGM
Conversations with patients who may be intimidated to try CGM
Empower more experienced CGM users to get the most out of their CGM system
Your clinic to educate new staff

Download Resource

Training Materials

Training Materials - Downloads

Understanding Your Glucose Using Real-Time CGM: A Playbook for your Health

Training Resources

cgm-101-you-and-your-dexcom-g7..pdf

Related Resources

Real-time CGM: The FIRST Tool for Managing Type 2 Diabetes

Premium Content

Off

Podcast Episode 19: Exercise, Type 1 Diabetes and CGM - Cutting Edge Insights from Recent Studies

OlgaDalisay — Wed, 14 Feb 2024 22:39:00 +0000

Podcast Episode 19: Exercise, Type 1 Diabetes and CGM - Cutting Edge Insights from Recent Studies

02/14/2024

OlgaDalisay Wed, 02/14/2024 - 22:39

Image shown does not include required overpatch. Please be sure to follow instructions for using the overpatch.

Guest Speaker: Dr. Dessi P. Zaharieva, PhD, CEP, CDCES

Real-time real talk is intended for healthcare professionals in the US.

In another episode of Real Time Real Talk, host Cher Pastore invites Dr. Dessi P. Zaharieva, to discuss all things diabetes. Dessi completed her PhD in Kinesiology & Health Science at York University under the supervision of leading diabetes researcher, Dr. Michael Riddell. She is currently working with Dr. David Maahs and the University of Stanford team to improve clinical outcomes in youth with type 1 diabetes.

Dessi Zaharieva's research focuses on effective strategies to reduce blood sugar fluctuations (i.e. hypoglycemia) during exercise and in recovery in individuals with type 1 diabetes.

Dessi has been living with type 1 diabetes for over 25 years and is also an award-winning high-level athlete within Brazilian Ju-Jitsu. She understands the challenges associated with exercise and blood glucose control and is very passionate about diabetes research, specifically the body’s response to different types of physical activity.

During the episode, Dessi runs through some clinical studies and interprets insights from them to provide practical and valuable advice on various types of exercise, insulin doses, and current glucose trends.

The speakers also explore the importance of continuous glucose monitoring in managing diabetes and the role played by patient-centered care. Finally, Dessi explores how technology advancements in health care have led to the development of tools that simplify guideline applications in practical real-time scenarios.

Learn how professional health care specialists like Dessi harness the knowledge gained over decades of research to ensure that it translates into ready-to-use strategies for those with diabetes.

Clinical Evidence - Type 1 Diabetes

Expert Presentations - Type 1 Diabetes

Podcast Episode 11: "Don't Let Diabetes Define Your Life" - Conversations with Ariana Frayer

Podcasts

Yes

Related Resources

Systematic Review of Commercial Hybrid Closed-Loop AID Systems

Premium Content

Off

Podcast Episode 18: CGM + GLP-1s - A Dynamic Duo for Diabetes

OlgaDalisay — Fri, 19 Jan 2024 02:53:21 +0000

Podcast Episode 18: CGM + GLP-1s - A Dynamic Duo for Diabetes

01/18/2024

OlgaDalisay Fri, 01/19/2024 - 02:53

Guest Speaker: Dr. Timothy Gilbert, MD

Real-time real talk is intended for healthcare professionals in the US.

GLP-1 medications have been around since early 2000s but only recently started getting more media coverage, thanks to celebrities and influencers. In this episode of Real-Time, Real Talk host Cher Pastore speaks to acclaimed Timothy Gilbert, MD, a clinical endocrinologist with over 15 years of experience in diabetes management. He has a practice in Louisiana where he and his team, including physicians, nurses, dieticians, and diabetes care and education specialists see many patients every day.

Dr Gilbert will demystify this extremely popular weight loss drug, explain the clinical indications for use, when it is beneficial for the patient, and in what scenario GLP-1 may or may not be the best choice. Using examples from his practice, he will answer the question we all been waiting for: how does CGM and GLP-1 medication work together, and what key role CGM plays in optimizing therapy.

Podcast

Clinical Evidence - Type 2 Diabetes

Synergistic use of CGM and GLP-1 Agonists for Type 2 Diabetes

Podcasts

Yes

Timothy Gilbert, MD

Timothy Gilbert, MD is an endocrinology, diabetes & metabolism specialist in Lake Charles, LA. Dr. Gilbert has extensive experience in Gonadal Endocrine Disorders, Osteoporosis & Screening, and Thyroid Disorders. Dr. Gilbert is considered a key opinion leader in the field of diabetes and has served in various clinical, management and consultant roles. The practice places a strong emphasis on early and aggressive intervention in patients with diabetes utilizing the most up to date therapies available.

Related Resources

ADA 2024: Empowering People with Type 2 Diabetes

Premium Content

Off

Podcast Episode 11: "Don't Let Diabetes Define Your Life" - Conversations with Ariana Frayer

OlgaDalisay — Tue, 20 Jun 2023 18:06:16 +0000

Podcast Episode 11: "Don't Let Diabetes Define Your Life" - Conversations with Ariana Frayer

06/20/2023

OlgaDalisay Tue, 06/20/2023 - 18:06

Guest speaker: Ariana Frayer

Real-time real talk is intended for healthcare professionals in the US.

In this episode of Real-Time Real Talk we wanted to highlight a different perspective on diabetes and diabetes management - through the eyes of a patient and a person living with diabetes.

Ariana Frayer is a business owner and a blogger. She also has type 1 diabetes. Over the years, she has become more open about her diabetes and a day-to-day management. Her mission is to share knowledge, inspire growth and unite those with the same condition.

This episode is an opportunity for any healthcare professional to hear the patient side of the story, and learn more about the human behind the numbers.

Check out Ariana's website - Cup of OJ

^{Ariana Frayer is a paid spokesperson for Dexcom and a Dexcom Warrior}

Podcast

Clinical Evidence - Type 1 Diabetes

Podcasts

Yes

Premium Content

Off

Highlights from APhA 2023

OlgaDalisay — Mon, 10 Apr 2023 23:43:22 +0000

Highlights from APhA 2023

04/10/2023

OlgaDalisay Mon, 04/10/2023 - 23:43

American Pharmacists Association (APhA) Annual Meeting brings together pharmacists from all practice settings and experience levels to connect and learn about new opportunities to transform the future of pharmacy care.

As continuous glucose monitoring becomes more accessible in pharmacy, we invite you to revisit this product theater to learn about:

- The latest in CGM technology

- How to identify new patients who can benefit from this technology

- New features of the Dexcom CGM that can benefit patients with Type 1 and Type 2 diabetes.

In addition, we will review stepwise approach to data interpretation using Dexcom Clarity.

Presenter:

For your convenience, this presentation is broken down into 3 parts, each is its own separate topic, following the same patient case study.

Part 1. Introducing the Next Generation of CGM

Part 2. The Role of Dexcom Clarity in Data Interpretation

Part 3. CGM Reimbursement

You can learn more about the Stepwise Approach here.

Expert Presentations - Data Interpretation

Expert Presentations - Data Interpretation

Expert Presentations

Data Interpretation

Country

United States

Premium Content

Ambulatory Glucose Profile (AGP) Report: The EKG of Diabetes Management

OlgaDalisay — Thu, 08 Dec 2022 22:32:08 +0000

Ambulatory Glucose Profile (AGP) Report: The EKG of Diabetes Management

12/08/2022

OlgaDalisay Thu, 12/08/2022 - 22:32

Cardiometabolic Health Congress (CMHC) leads the medical community’s effort to understand, treat, and prevent cardiometabolic-related risk factors and diseases, which now affect an estimated 47 million people in the U.S.

This presentation was recorded during the recent conference.During this session we will discuss:

The value of adding AGP metrics, such as time in range (TIR), to your diabetes management process.
Recent research that demonstrates the benefits of real-time CGM for people living with both type 2 and type 1 diabetes.
Case studies and will review AGP report data and discuss how to apply clinical guidelines to support diabetes medication selection.

Events

Expert Presentations

Expert Presentations - Type 1 Diabetes

T1D

Related Resources

New Efficient Way for Primary Care Providers to Analyze CGM Data

Premium Content

Off

Enhanced Capabilities of Automated Insulin Delivery (AID) System

OlgaDalisay — Wed, 16 Nov 2022 22:51:36 +0000

Enhanced Capabilities of Automated Insulin Delivery (AID) System

11/16/2022

OlgaDalisay Wed, 11/16/2022 - 22:51

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery (AID) System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes (T1D)

Background

Automated Insulin Delivery (AID) systems have been shown to improve glycemic control and reduce hypoglycemia, but the burden of T1D is significant. This study focuses on researching the enhanced capabilities of a recent system.

Objective

The purpose of this study was to assess the safety and effectiveness of the first tubeless, on-body AID system.

Methods

This tubeless automated insulin delivery system was safe, and allowed participants to significantly improve A1C levels and Time in Range (TIR) with a very low occurrence of hypoglycemia.

Results

Download PDF

† Recommendations from the International Consensus on Time in Range, 2019 recommend individualized glycemic targets for high risk and/or older adults with a focus on reducing the percentage of time spent less than 70 md/dL and preventing excessive hyperglycemia.

1. Sue A. Brown, Gregory P. Forlenza, Bruce W. Bode, Jordan E. Pinsker, et al Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic

Targets in Pediatric and Adult Participants With Type 1 Diabetes; Diabetes Care 2021;44(7):1–11 | https://doi.org/10.2337/dc21-0172

Clinical Evidence - Automated Insulin Delivery

Clinical Evidence - Type 1 Diabetes

Training Materials - Downloads

Training Materials